ANTHEM.NS
Cash Flow
Anthem Biosciences Ltd. · Healthcare
Cash Flow · 1 year on file
as of FY2025-26
· fetched 2026-09-23 02:01
| Line item | FY2025-26 | Source (XBRL element) |
|---|---|---|
| Net Cash from Operating Activities | ₹8.44 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-7.02 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-0.40 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹-0.00 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹1.03 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | CashAndCashEquivalentsCashFlowStatement |
| Dividends Paid | ₹0.00 Bn | DividendsPaidClassifiedAsFinancingActivities |
Every figure above is the exact value of the named XBRL element from ANTHEM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).